Evidence of fetal pulmonary aspiration of intra-amniotic administered surfactant in animal experiment

Journal of Perinatal Medicine

Volumn 32, Issue 4, 2004, Pages 354-358

  Illia, Ricardo ^a,c   Solana, Claudio ^b   Oliveri, Pedro ^a   Toblli, Jorge ^a   Imaz, Matias Uranga ^a   Häbich, Diego ^a  

^a HOSPITAL ALEMÁN   (Argentina)

^b Hospital Materno Infantil Ramon Sarda   (Argentina)

^c NONE   (Argentina)

Author keywords

Amniotic fluid; In utero therapy; Preterm delivery; Surfactant prophylaxis

Indexed keywords

AMINOPHYLLINE; CARMINIC ACID; NATSURF; SURFACTANT; TECHNETIUM 99M;

AMNIOCENTESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; BREATHING MECHANICS; CONTROLLED STUDY; DOSIMETRY; DRUG ADMINISTRATION ROUTE; DRUG CONCENTRATION; ESOPHAGUS; FETUS; FETUS LUNG; GUINEA PIG; INTRAAMNIOTIC DRUG ADMINISTRATION; KIDNEY; LIVER; LUNG; LUNG ASPIRATION; NEWBORN PERIOD; NONHUMAN; PLACENTA; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; STAINING; STOMACH; THIRD TRIMESTER PREGNANCY; TRACHEA;

AMNIOTIC FLUID; ANIMALS; FEMALE; GUINEA PIGS; HUMANS; INFANT, NEWBORN; INJECTIONS; LUNG; MODELS, ANIMAL; PLACENTA; PREGNANCY; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; STOMACH;

EID: 3543035223     PISSN: 03005577     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPM.2004.066     Document Type: Article

References (27)

1. Cosmi EV: Drugs and anesthetics in the management of preterm labor and delivery. In Cosmi EV (ed): Obstetric Anesthesia and Perinatology. Appleton-Century-Crofts, New York 1981, Chapter 7
2. Cosmi EV, R La Torre, R Di Iorio, MM Anceschi: Surfactant administration to the human fetus in utero: a new approach to prevention of neonatal respiratory distress syndrome (RDS). J Perinat Med 24 (1996) 191
3. Crowly P: Corticosteroids prior to preterm delivery. In: Nelson JP, CA Crowther, DE Hodnet, GJ Hofmeyr, MJNC Keirse (eds.): Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews, (updated 03 June 1997). The Cochrane Library. The Cochrane Collaboration, Issue 3, Oxford 1997 (Update Software)
4. Duenhoelter JH, JA Pritchhard: Human fetal respiration. II. Fate of intra-amniotic Hypaque and 51Cr-labeled red cells. Obstet Gynecol 43 (1974) 878
5. Dunn M, A Shennan, D Zayack, F Possmayer: Bovine surfactant replacement therapy in neonates less than 30 weeks' gestation: A randomized controlled trial of prophylaxis versus treatment. Pediatrics 87 (1991) 377
6. Enhorning G, A Shennan, F Possmayer, M Dunn, CP Chen, J Milligan: Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics 76 (1985) 145
7. Flake AW, RL Villa-Troyer, NS Adzick, MR Harrison: Transamniotic fetal feeding. III. The effect of nutrient infusion on fetal growth retardation. J Pediatr Surg 21 (1986) 481
8. Fujiwara T, H Maeta, S Chida, T Morita, Y Watabe, T Abe: Artificial surfactant therapy in hyaline membrane disease. Lancet 1 (1980) 55
9. Galan HL, TJ Kuehl: Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses. Obstet Gynecol 80 (1992) 604
10. Galan HL, C Cipriani, JJ Coalson, JD Bean, G Collier, TJ Kuehl: Surfactant replacement therapy in utero for prevention of hyaline membrane disease in the preterm baboon. Am J Obstet Gynecol 169 (1993) 817
11. Galan HL, C Cipriani, JJ Coalson, et al.: Hyaline membrane disease surfactant prophylaxis in the preterm baboon: a comparison of postpartum versus in utero therapy. Prenatal Neonatal Med 1 (1996) 122
12. Gilbert WM, PS Newman, E Eby-Wilkens, RA Brace: Technetium Tc 99 m rapidly crosses the ovine placenta and intramembranous pathway. Am J Obstet Gynecol 175 (1996) 1557
13. rd, ME Stern, WF Powers, M Maurer, JR Raye, ST Carrier, JH Gunkel, AJ Gold: Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics 88 (1991) 10
14. Kalache K, R Chaoui, R Bollmann: Doppler assessment of tracheal and nasal fluid flow during fetal breathing movements: preliminary observations. Ultrasound Obstet Gynecol 6 (1997) 257
15. Kendig JW, RH Notter, C Cox, JL Aschner, S Benn, RM Bernstein, K Hendricks-Munoz, WM Maniscalco, LA Metlay, DL Phelps, RA Sinkin, BP Wood, DL Shapiro: Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials. Pediatrics 82 (1988) 756
16. Kwong MS, EA Egan, RH Notter, DL Shapiro: Double blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics 76 (1985) 585
17. Maloney JE, TM Adamson, AV Brodecky, S Cranage, TF Lambert, BC Ritchie: Diaphragmatic activity and lung liquid flow in the unanesthetized fetal sheep. J Appl Physiol 39 (1975) 423
18. Meredith KS, RA DeLemos, JJ Coalson, RJ King, DR Gerstmann, R Kumar, TJ Kuehl, DC Winter, A Taylor, RH Clark: Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons. J Appl Physiol 66 (1989) 2150
19. Merritt TA, M Hallman, BT Bloom, C Berry, K Benirschke, D Sahn, T Key, D Edwards, AL Jarvenpaa, M Pohjavuori, K Kankaanpaa, M Kunnas, H Paatero, J Rapola, J Jaaskelainen: Prophylactic treatment of very premature infants with human surfactant. N Eng J Med 315 (1986) 785
20. Robertson B, G Enhorning: The alveolar lining of the premature newborn rabbit after pharyngeal deposition of surfactant. Lab Invest 31 (1974) 54
21. Scarpelli EM, E David, M Cordova, AJ Mautone: Surface tension of therapeutic surfactant (Exosurf Neonatal, Infasurf and Survanta) as evaluated by standard methods and criteria. Am J Perinat 9 (1992) 414
22. Snyder FF, M Rosenfeld: Direct observation of intra-uterine respiratory movements of the fetus and the role of carbon dioxide and oxygen in their regulation. Am J Physiol 119 (1937) 153
23. Solana C, C Osio, S Lujan, C Vecchiarelli, M Larguia, O Stoliar, L Prudent: Surfactante pulmonar exógeno en el tratamiento de la enfermedad de membrana hialina severa: efectos agudos. Arch Arg Pediatr 91 (1993) 65
24. Soll RF, RE Hoekstra, JJ Fangman, AJ Corbet, JM Adams, LS James, K Schulze, W Oh, JD Roberts, JP Dorst, SS Dramer, AJ Gold, EM Zola, JD Horbar, TL McAuliffe, JF Lucey: Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. Pediatrics 85 (1990) 1092
25. Soll RF: Natural surfactant extract vs. synthetic surfactant in the treatment of established respiratory distress syndrome. Neonatal Module of The Cochrane Database of Systematic Reviews, [updated 27 May 1997]. The Cochrane Library. The Cochrane Collaboration; Issue 1. Oxford 1997 (Update Software)
26. Soll RF: Prophylactic administration of natural surfactant extract. In: JC Sinclair, MB Bracken, RF Soll, JD Horbar (eds): Neonatal Module of The Cochrane Database of Systematic Reviews, [updated 02 December 1997]. The Cochrane Library. The Cochrane Collaboration; Issue 1. Oxford 1998 (Update Software)
27. Walther F, I Kuipers, CE Gidding, D Willebrand, RT Buchholtz, EM Bevers: A comparison of high-frequency oscillation superimposed onto backup mechanical ventilation and conventional mechanical ventilation on the distribution of exogenous surfactant in premature lambs. Pediatr Res 22 (1987) 725